Furthermore, in an analysis of isolated uterine microvascular cells, pravastatin decreased the release of other factors associated with endothelial dysfunction, such as endothelin-1 (ET-1), without loss of cell viability.(18). Here, EDN1 is linked to endothelial dysfunction.